Company JHL Biotech, Inc.

6540

KYG7863U1076

Managers

Members of the board

Share class

Company contact information

Sector

Sector Biopharmaceuticals

Inactive Instrument

JHL BIOTECH, INC. is a Taiwan-based company principally engaged in development and manufacturing of biopharmaceuticals. The Company provides cell line cloning, process development, and manufacturing capabilities and services to emerging and established biopharmaceutical companies seeking to collaboratively develop, manufacture and commercialize biologics.

Managers	Title	Age	Since
Raco Ivan Jordanov CEO	Chief Executive Officer	76	11/06/12
Ellis Chu DFI	Director of Finance/CFO	-	30/04/18
Cui WeiDong CTO	Chief Tech/Sci/R&D Officer	-	-
Rong Chen CTO	Chief Tech/Sci/R&D Officer	-	31/12/17
DJ Lin LAW	General Counsel	-	30/03/17
Jill Liu AUD	Comptroller/Controller/Auditor	-	31/12/14
Peter Pang LAW	General Counsel	-	31/10/14
Nick Kotlarski PRN	Corporate Officer/Principal	-	-
Andreas Nechansky PRN	Corporate Officer/Principal	-	-
Max Chan AUD	Comptroller/Controller/Auditor	56	19/10/15

Members of the board	Title	Age	Since
Zuie Chin Huang CHM	Chairman	58	16/12/12
Bryant Fong BRD	Director/Board Member	51	16/12/12
Yi Hsiung Chen BRD	Director/Board Member	-	13/05/15
Ying Du BRD	Director/Board Member	59	16/12/12
Raco Ivan Jordanov CEO	Chief Executive Officer	76	11/06/12
Rose Lin FOU	Founder	-	11/06/12
Jun Wu BRD	Director/Board Member	-	13/05/15
Chia Lin Wang BRD	Director/Board Member	-	13/05/15
Fang Hsi Teng BRD	Director/Board Member	-	13/05/15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	220,403,607	220,403,607 ( 100.00 %)	0	100.00 %

Eden Biologics, Inc.

5/F, No.18, Section 2 Shengyi Road

302, Zhubei

http://www.jhlbiotech.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-1.26%	89.46B
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	40.74B
BIOGEN INC.	-8.93%	33.03B
UCB	+55.32%	24.68B
BIOMARIN PHARMACEUTICAL INC.	-16.10%	15.12B
INCYTE CORPORATION	-8.73%	12.81B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.11%	11.79B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.61%	11.64B
SWEDISH ORPHAN BIOVITRUM AB	+7.79%	8.9B

Biopharmaceuticals